Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Vivos →

  California-based company, that provdes hardened underground shelters designed to withstand future disasters and life-extinction catastrophes

  Nothing else this week.

• United States Patent and Trademark Office →

  agency in the United States Department of Commerce

  • The administration barred several media outlets from White House grounds while a private company filed a trademark application with the USPTO.Sun 02:39
  • The United States Patent and Trademark Office is addressing the establishment of professional conduct standards regarding the use of artificial intelligence in its processes.Fri 02:41

Related events

• An alert was issued regarding high-risk failures in CPAP devices manufactured by CooperSurgical.Aug 26
• An unnamed company secured regulatory approval in July 2025, leading to a $2.5 million milestone reported today.Aug 19
• Congress considered proposals to strengthen FDA authority regarding medical device regulation and minimum standards.Jun 7
• Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.Aug 27
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17